Scientific Advisory Board
Our scientific advisory board is more than just experts that provide their names on a website. Our scientific experts are actively involved in the projects – if desired by our customers – and contribute with their long-year experience in the development of protein therapeutics. They support the projects for our clients, by providing scientific input to project planning, discussion of the results, reporting, IP and regulatory questions. Depending on the wishes of our clients, the degree of input from the scientific advisory board is set up and can range from occasional consulting on specific topics to a regular supervision of a project from the planning until the reporting phase. Together with you as our customers we tailor the type and extent of input for your project. The scientific advice is provided independently from the universities in order to ensure the highest level of protection of our customer's entrusted information. No additional contracts with the universities are required to benefit from the scientific advice of our experts.
Prof. Dr. Gerhard Winter
Ludwig-Maximilians University Munich (LMU)
Department of Pharmacy
Pharmaceutical Technology & Biopharmaceutics
Prof. Dr. Gerhard Winter is expert in formulation development and delivery of biopharmaceutical drugs and, colloidal drug carriers, parenteral process technologies and lyophilization. Before becoming professor for Pharmaceutical Technology and Biopharmaceutics at the LMU Munich in 1999, he has been working in the pharmaceutical industry for more than 12 years with positions at Merck, Boehringer Mannheim and Roche. During his industry years Dr. Winter was responsible i.a. for market formulations of erythropoietin, ibandronate and reteplase. He led a formulations research team on parenteral drugs, focusing on biotec products and in parallel headed a large scale clinical supplies unit for aseptically manufactured injectables, including manufacture of freeze-dried products. His responsibilities span from preformulation and interface management with downstream processing to formulation development, stability studies, upscaling and CMC dossier preparation.
Prof. Dr. Wolfgang Friess
Ludwig-Maximilians University Munich (LMU)
Department of Pharmacy
Pharmaceutical Technology & Biopharmaceutics
Prof. Dr. Wolfgang Friess is expert in protein formulation (with special interest in highly concentrated formulations, protein adsorption), drying technologies (spray-drying), drug delivery and biomaterials. Since 2001 he is appointed as professor for Pharmaceutical Technology and Biopharmaceutics at the LMU Munich. Prior to this he has been working at University of Erlangen, Genetics Institute (now Pfizer) Andover, MA and University of Illinois (Chicago).
Prof. Dr. Wim Jiskoot
Leiden University
Leiden Amsterdam Center for Drug Research (LACDR)
Division of Drug Delivery Technology
Wim Jiskoot is expert in vaccine formulation and delivery, as well as in protein formulation development especially with respect to unwanted immunogenicity in relation with protein structure and formulation. Wim Jiskoot graduated as a pharmacist and obtained his PhD degree at Utrecht University (1991). As a postdoc at the University of Utah he studied protein-ligand interactions using biophysical techniques. In 1994 he became head of the Department of Bacterial Vaccine Development at the Laboratory for Product and Process Development, National Institute of Public Health and the Environment (RIVM), Bilthoven, where he was in charge of the development of production processes for bacterial vaccines. In 1998 he became a staff member at the Department of Pharmaceutics, Utrecht University, where he worked in the field of formulation, delivery and physicochemical characterization of therapeutic proteins and vaccines. Since 2006 he is professor at the Division of Drug Delivery Technology, Leiden/Amsterdam Center for Drug Research (LACDR), Leiden University.
Prof. Dr. John F. Carpenter
University of Colorado, School of Pharmacy
University of Colorado Center for Pharmaceutical Biotechnology
John F. Carpenter is expert in mechanisms for protein degradation and stabilization in pharmaceutical formulations, during bioprocessing and in delivery systems. Also, he has worked for several years to define rational strategies for stabilizing proteins and vaccines during freeze-drying and storage in the dried solid. He has published more than 200 peer-reviewed papers and is an inventor on 19 issued patents. He is Editor for Reviews and Commentaries for Journal of Pharmaceutical Sciences and. serves on the Editorial Advisory Boards for various pharmaceutical journals.